"/> Invitrogen™ Peptide synthétique CD229 humain | B-LABO France

Invitrogen™ Peptide synthétique CD229 humain

Réf. : BL-RE-176297Réf. fabricant : 15265249 50 μg
137,00 € HT

Synthetic Peptide

Gene ID (Entrez)
4063
Espèces
Human
Méthode de purification
purified
Numéro d’adhésion
Q9HBG7
Nom usuel
Human CD229
Marque
Invitrogen

SLAMF3 Synthetic Peptide, PEP-1249, from Invitrogen.

CD229 (Ly9) is a cell surface receptor of the CD150 family, which includes also e.g. CD48 and CD224. Receptors of this family regulate cytokine production and cytotoxicity of lymphocytes and NK cells. High levels of CD229 are found on T and B cells, where its expression increases during their maturation. It is absent on granulocytes, bone marrow-derived dendritic cells, platelets and erythrocytes. CD229 has been also reported on mouse monocytes and NK cells. CD229 interacts homophilically through its N-terminal domain and localizes to the contact site between T cells and antigen presenting B cells during antigen-dependent immune synapse formation.

Caractéristiques techniques

MarqueInvitrogen
Réf. B-LABOBL-RE-176297
Réf. fabricant15265249
Gene ID (Entrez)4063
EspècesHuman
Méthode de purificationpurified
Numéro d’adhésionQ9HBG7
Nom usuelHuman CD229
Concentration200 μg/mL
Contenu et stockage-20°C
FormatLiquid
FormulePBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
À utiliser avec (application)Blocking Assay, Control
Symbole de gène(s)LY9
LyophiliséNo
Conservateur0.02% sodium azide
Type de produitPeptide
Quantité50 μg
État réglementaireRUO - research use only
Tampon de stockagePBS
Une question, une configuration particulière ?
Contactez-nous pour un devis.